Elucidating the Three‐Dimensional Structure of Piracetam through Rotational Spectroscopy [PDF]
ChemistryOpenHerein we report on the most stable structures adopted by piracetam, a nootropic drug, in isolated conditions. A chirped pulse Fourier transform microwave spectrometer (CP‐FTMW) coupled with a laser ablation source has been employed to explore the ...
S. Mato +4 more
doaj +3 more sources
Investigation of the Formation Process of Two Piracetam Cocrystals during Grinding
Pharmaceutics, 2011 Cocrystal formation rates during dry grinding and liquid-assisted grinding were investigated by X-ray powder diffractometry and Raman spectroscopy. Two polymorphic forms of piracetam were used to prepare known piracetam cocrystals as model substances, i ...
Clare J Strachan, , Thomas Rades
exaly +3 more sources
Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss [PDF]
PharmaceuticsBackground: Fixed-dose combinations have advanced in many therapeutic areas, including otorhinolaryngology, where hearing disorders are increasingly prevalent.
Lucia Maria Rus +12 more
doaj +2 more sources
Effectiveness and Safety of Ginkgo biloba, Vinpocetine and Piracetam as a Single Agent and Fixed Dose Combination in Patients with Subjective Tinnitus [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Owing to the lack of any standard treatment, subjective tinnitus can be debilitating, manifesting a varied population response to tinnitus management.
Paul Mathai, Anu Chandran, Sourav Das
doaj +1 more source
Dissociative symptoms secondary to piracetam: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Piracetam is a cyclic derivative of gamma-aminobutyric acid that is often used in neurology. Piracetam is an antithrombotic, neuroprotective agent which improves cognitive performance. Piracetam is indicated for vertigo in clinical practice.
Adem Aydin +4 more
doaj +1 more source
Current Research in Pharmacology and Drug Discovery, 2021 Alzheimer's disease is a cerebrovascular disorder characterized by progressive loss of the mental capabilities. The novel therapeutic agent piracetam is a cyclic derivative of γ-aminobutyric acid and one of the oldest recognized synthetic nootropics ...
Subhash Chaturvedi +3 more
doaj +1 more source
Brazilian Journal of Pharmaceutical Sciences, 2023 Therapeutically, piracetam has been used for decades as a cognitive enhancer for memory- related neuronal disorders. The present study aimed to investigate the neuroprotective potential of piracetam on lipopolysaccharides (LPS)-induced neuronal deficit ...
Vasudevan Mani
doaj +1 more source
Advanced Biomedical Research, 2021 Background: We aimed to compare the effectiveness of Levetiracetam and Piracetam on the severity and frequency of spells in children with severe breath-holding spells (BHS), i.e.
Mohammad Reza Ghazavi +5 more
doaj +1 more source
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study. [PDF]
PLoS ONE, 2013 Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on age-related cognitive decline often leading to inconclusive results due to small sample ...
Hélène Amieva +4 more
doaj +1 more source
Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering [PDF]
, 2020 OBJECTIVE: The authors have sought to expound upon and shed a light on the rise of nootropics, which have gradually taken on a more and more relevant role in workplaces and academic settings.
Bersani, G +5 more
core +1 more source